NCT06830785Recruiting
Effects of RAS in Stroke
Effects of Rhythmic Auditory Stimulation on Upper-limb Movements, Function, and Quality of Life in Stroke Patients: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 25 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this study is to to examine whether rhythmic auditory stimulation improved movement speed, movement function of executing activities of daily living, and movement recovery of the affected upper limb, as well as quality of life in stroke patients. The main questions it aims to answer are: * Does rhythmic auditory stimulation improve movement speed in stroke patients? * Does rhythmic auditory stimulation improve movement function of executing activities of daily living in stroke patients? * Does rhythmic auditory stimulation improve movement recovery of the affected upper limb in stroke patients? * Does rhythmic auditory stimulation improve quality of life in stroke patients? Researchers will compare movement training with the aid of rhythmic auditory stimulation to movement training without the aid of rhythmic auditory stimulation to see if rhythmic auditory stimulation works to improve movement speed, movement function of executing activities of daily living, and movement recovery of the affected upper limb, as well as quality of life in stroke patients. Participants will: * Undergo movement tests and fill out questionnaires before and after the movement training program * Receive movement training for 40 minutes per session and three sessions per week for a total of 24 sessions
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- First submitted
- 11 Feb 2025
- Start date
- 26 Mar 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Shu-Mei Wang
- Diseases
- Stroke
- NCT number
- NCT06830785
What you commit to
- Study type: Interventional
- Planned participants: 68
- From 26 Mar 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- (2) Being participating in other experimental studies related to drug treatment or upper-limb movement therapy.
Other illness
- (1) Neurological diseases or medical conditions that affect upper-limb movements or hearing;
Who the study is looking for
- (1) Diagnosed with either ischaemic or hemorrhagic stroke, and a first-time occurrence;
- (2) A unilateral stroke;
- (3) The onset occurred six months or more prior to the experiment, indicating a chronic stage of stroke;
- (4) The affected upper limb's proximal and distal joints are between Brunnstrom stages four to six, ensuring that the affected limb can execute the upper-limb functional movement training of this study;
- (5) The affected upper limb's Modified Ashworth Scale score is ≤ 2, indicating no significant muscle stiffness (spasticity) in the affected limb;
- (6) A Montreal Cognitive Assessment score of ≥ 24, ensuring comprehension of the instructions given during this study;
- and (7) when we clap hands next to the affected ear of the participant who closes eyes, the participant is able to indicate the sound's source either verbally or through gestures, indicating no complete hearing loss in the affected ear and the ability to receive rhythmic auditory stimulation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taipei University of Nursing and Health Sciences Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.